Researchers interviewed 169 practicing gastroenterologists and 22 academic experts to determine the treatment recommended and the treatment actually given. Differences were found in the use of IgA anti-endomysial antibodies, human leukocyte antigen DQ2/8 testing, gluten challenge and oat consumption.
Academic experts more frequently recommended CD screening for patients with type 1 diabetes and Down and Turner syndromes, as well as for relatives of CD patients.
Related Articles on Celiac Disease:
Celiac Cases Rising, Cause Unknown
Mayo Clinic Gastroenterologist Details Role of Endoscopic Imaging in Small Bowel
Texas Gastroenterologist Featured for Use of Capsule Endoscopy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.